GlassScriptPhysician profile
Christine Ruehl
NPI 1487881611
$2,284.32
in general payments reported to CMS, 2019-2025
27 companies · $318 in 2025
The $318 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $329 · 2020: $65.55 · 2021: $106 · 2022: $353 · 2023: $706 · 2024: $407 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,170 · Education: $261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,169.59 |
| Education | $260.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $633.15 | 2019-2025 | Orilissa, Liletta, Lo Loestrin Fe |
| Astellas Pharma US INC | $523.96 | 2023-2025 | Veozah, Myrbetriq |
| Myriad Women'S Health, INC. | $184.97 | 2023 | Myrisk |
| Pfizer INC. | $154.86 | 2022-2024 | |
| Biogen, INC. | $109.25 | 2025 | Zurzuvae |
| Coopersurgical, INC. | $88.82 | 2019-2023 | Paragard T 380a |
| Organon LLC | $71.53 | 2024-2025 | Jada System, Nexplanon |
| Hologic Sales and Service, LLC | $69.55 | 2019-2025 | Myosure Tissue Removal Device |
| Sumitomo Pharma America, INC. | $54.35 | 2023-2024 | Myfembree |
| Lupin INC. | $43.38 | 2019-2020 | |
| Smith+Nephew, INC. | $40.99 | 2022-2023 | Pico 7 |
| Bayer Healthcare Pharmaceuticals INC. | $31.50 | 2019-2020 | |
| Minerva Surgical, INC | $30.27 | 2019-2025 | |
| Medtronic, INC. | $30.00 | 2024 | Interstim |
| Sanofi Pasteur INC. | $25.89 | 2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $23.55 | 2023 | Phexxi |
| Solventum Corporation | $20.96 | 2025 | Prevena |
| Baxter Healthcare | $19.50 | 2022 | |
| Ethicon US, LLC | $16.69 | 2021 | |
| Scynexis, INC. | $15.61 | 2022 | |
| Optumhealth Care Solutions, LLC | $15.48 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Daiichi Sankyo INC. | $14.37 | 2022 | |
| Asensus Surgical, INC. | $14.34 | 2019 | |
| Mylan Pharmaceuticals INC. | $13.99 | 2021 | |
| Myovant Sciences INC. | $13.19 | 2022 | |
| Covidien LP | $13.07 | 2019 | |
| Meditrina | $11.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Ruehl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.